Dr. Fineman received his medical degree from the New York University School of Medicine. He completed pediatric residency and Chief Residency at NYU/Bellevue Medical Center, followed by a critical care fellowship at UCSF. Dr. Fineman is a Professor and Vice Chair of Pediatrics, Director of Critical Care Medicine, Director of the Pediatric Pulmonary Hypertension Service, and Investigator of the Cardiovascular Research Institute at the University of California, San Francisco, Benioff Children’s Hospital, where he is the Director of the Pediatric Translational Research Core Facility. Dr. Fineman leads an NIH funded research program studying the regulation of pulmonary blood flow and pulmonary vascular resistance in the normal and abnormal fetal, transitional, and postnatal circulations, utilizing clinically relevant large animal models of disease. In particular, his focus has been on the role of endothelial function in these systems. In addition, Dr. Fineman directs clinical-translational projects investigating molecules with potential as biomarkers to predict outcome after cardiothoracic surgery for congenital heart disease and is involved in clinical projects investigating agents for therapy and prevention of pulmonary hypertension. His laboratory has been funded by the American Heart Association, the March of Dimes, the Leducq Foundation, and the NIH. He is the recipient of numerous honors and awards including the John J. Sampson Award in Research, an Established Investigator Award, and a Mentoring Award from the American Heart Association. In addition, he is an Associate Editor of the American Journal of Physiology, Pediatric Critical Care Medicine, and Pulmonary Circulation, a member of the Scientific Advisory Committee for the NIH K12 in Pediatric Critical Care, and PI of a Pediatric Critical Care Medicine NIH T32 program.